AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: A guideline from the American Heart Association and American College of Cardiology Foundation

Sidney C. Smith*, Emelia J. Benjamin, Robert O. Bonow, Lynne T. Braun, Mark A. Creager, Barry A. Franklin, Raymond J. Gibbons, Scott M. Grundy, Loren F. Hiratzka, Daniel W. Jones, Donald M. Lloyd-Jones, Margo Minissian, Lori Mosca, Eric D. Peterson, Ralph L. Sacco, John Spertus, James H. Stein, Kathryn A. Taubert

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1108 Scopus citations
Original languageEnglish (US)
Pages (from-to)2458-2473
Number of pages16
Issue number22
StatePublished - Nov 29 2011


  • AHA Scientific Statements
  • coronary disease
  • risk factors
  • secondary prevention
  • vascular disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this